Macquarie Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-163,578
| Closed | -$2.94M | – | 2393 |
|
|
2020
Q2 | $2.94M | Sell |
163,578
-335,888
| -67% | -$4.67M | 0.01% | 909 |
|
|
2020
Q1 | $3.56M | Sell |
499,466
-70,968
| -12% | -$886K | 0.01% | 791 |
|
|
2019
Q4 | $13.6M | Buy |
570,434
+21,752
| +4% | +$600K | 0.02% | 594 |
|
|
2019
Q3 | $14.7M | Buy |
548,682
+43,469
| +9% | +$1.22M | 0.02% | 520 |
|
|
2019
Q2 | $13.7M | Sell |
505,213
-43,066
| -8% | -$1.35M | 0.02% | 544 |
|
|
2019
Q1 | $19M | Sell |
548,279
-37,299
| -6% | -$1.08M | 0.03% | 474 |
|
|
2018
Q4 | $11.4M | Buy |
585,578
+205,220
| +54% | +$4.22M | 0.02% | 573 |
|
|
2018
Q3 | $10.1M | Buy |
380,358
+207,358
| +120% | +$6.77M | 0.02% | 642 |
|
|
2018
Q2 | $6.53M | Buy |
+173,000
| New | +$6.62M | 0.01% | 721 |
|
|
2017
Q1 | – | Sell |
-39,201
| Closed | -$880K | – | 1584 |
|
|
2016
Q4 | $880K | Hold |
39,201
| – | – | ﹤0.01% | 1190 |
|
|
2016
Q3 | $890K | Sell |
39,201
-32,099
| -45% | -$753K | ﹤0.01% | 1176 |
|
|
2016
Q2 | $1.68M | Buy |
71,300
+45,100
| +172% | +$1.11M | ﹤0.01% | 1185 |
|
|
2016
Q1 | $534K | Sell |
26,200
-18,621
| -42% | -$591K | ﹤0.01% | 1224 |
|
|
2015
Q4 | $2.31M | Buy |
44,821
+581
| +1% | +$28.2K | ﹤0.01% | 901 |
|
|
2015
Q3 | $1.89M | Sell |
44,240
-23,572
| -35% | -$1.14M | ﹤0.01% | 986 |
|
|
2015
Q2 | $3.09M | Buy |
67,812
+36
| +0.1% | +$1.45K | 0.01% | 902 |
|
|
2015
Q1 | $2.57M | Buy |
67,776
+3,292
| +5% | +$113K | 0.01% | 949 |
|
|
2014
Q4 | $1.83M | Buy |
64,484
+4,301
| +7% | +$120K | ﹤0.01% | 1041 |
|
|
2014
Q3 | $1.52M | Buy |
60,183
+353
| +0.6% | +$9.3K | ﹤0.01% | 1081 |
|
|
2014
Q2 | $1.75M | Buy |
59,830
+1,412
| +2% | +$34.2K | ﹤0.01% | 1084 |
|
|
2014
Q1 | $1.51M | Buy |
58,418
+4,735
| +9% | +$126K | ﹤0.01% | 1086 |
|
|
2013
Q4 | $1.38M | Buy |
+53,683
| New | +$1.3M | ﹤0.01% | 1091 |
|
Macquarie Group's PTLA Position: Q3 2020 in Review
Macquarie Group sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 163,578 shares — an estimated $2.94M sold.
Macquarie Group first reported a position in PTLA in Q4 2013 and held it in 22 quarters. The position peaked at $19M in Q1 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Macquarie Group reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Macquarie Group sold 163,578 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $2.94M.
- Macquarie Group first reported a position in Portola Pharmaceuticals, Inc. in Q4 2013 and held it in 22 quarters.
- Macquarie Group's Portola Pharmaceuticals, Inc. position peaked at $19M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Macquarie Group's 13F filing for Q3 2020, filed 13 Nov 2020.